ETON 8-K 2026-09-28
Eton Pharmaceuticals, Inc. (ETON) 8-K dated 2026-09-28 — accession 0001437749-26-031281.
Eton Pharmaceuticals, Inc. (ETON) is a drug manufacturers - specialty & generic company listed on US.
Eton Pharmaceuticals, Inc. filed a 8-K on 2026-09-28. Accession 0001437749-26-031281.
This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported ETON revenue for 2025-12-31 was $80.0M. Net income was -$4.6M. Revenue was up 104.9% from 2024-12-31 to 2025-12-31. ETON currently screens at market cap $797.9M.
Not investment advice. The ETON SEC hub lists recent forms. The stock page is the research view.